BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35494008)

  • 1. Survival Analysis in Male Breast Cancer With Bone Metastasis Based on the SEER Database.
    Zhou X; Zhang J; Wang Y; Cao Z
    Front Oncol; 2022; 12():659812. PubMed ID: 35494008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics and Prognosis in Endometrial Cancer With Bone Metastasis: A SEER-Based Study of 584 Women.
    Hu H; Wang Z; Zhang M; Niu F; Yu Q; Ren Y; Ye Z
    Front Oncol; 2021; 11():694718. PubMed ID: 34277441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Analysis in Gastrointestinal Neuroendocrine Carcinoma With Bone Metastasis at Diagnosis.
    Chen G; Xu Q; Qian S; Wang Z; Wang S
    Front Surg; 2022; 9():820725. PubMed ID: 35155558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
    Gao X; Zhang F; Zhou Q; Xu H; Bian J
    PLoS One; 2023; 18(11):e0293830. PubMed ID: 37917616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis.
    Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
    Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Verification of Prognostic Nomograms for Young Women With Breast Cancer Bone Metastasis.
    Wang Z; Shao H; Xu Q; Wang Y; Ma Y; Diaty DM; Zhang J; Ye Z
    Front Med (Lausanne); 2022; 9():840024. PubMed ID: 35492327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis.
    He B; Mao J; Huang L
    Front Oncol; 2021; 11():677023. PubMed ID: 34141621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
    Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
    BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study.
    Xue M; Chen G; Chen X; Hu J
    Medicine (Baltimore); 2021 Aug; 100(34):e27070. PubMed ID: 34449503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prognostic nomograms for female patients with breast cancer and bone metastasis at presentation.
    Wang Z; Cheng Y; Chen S; Shao H; Chen X; Wang Z; Wang Y; Zhou H; Chen T; Lin N; Ye Z
    Ann Transl Med; 2020 Mar; 8(5):197. PubMed ID: 32309344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features, Prognostic Factors and Survival in Patients With Pancreatic Cancer Bone Metastasis.
    Ren Y; Wang S; Wu B; Wang Z
    Front Oncol; 2022; 12():759403. PubMed ID: 35223464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.
    Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
    Med Sci Monit; 2019 Jul; 25():5525-5535. PubMed ID: 31344019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting survival of patients with bone metastasis of unknown origin.
    Ren Y; Qian S; Xu G; Cai Z; Zhang N; Wang Z
    Front Endocrinol (Lausanne); 2023; 14():1193318. PubMed ID: 38027105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.
    Ren S; Wang Y; Wang Z; Shao J; Ye Z
    BMC Cancer; 2020 Aug; 20(1):778. PubMed ID: 32811474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis.
    Han Y; Sui Z; Jia Y; Wang H; Dong Y; Zhang H; Li Z; Yu Z
    J Cancer; 2021; 12(21):6445-6453. PubMed ID: 34659535
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis.
    Wang Z; Chen G; Chen X; Huang X; Liu M; Pan W; Yan X; Lin N; Ye Z
    J Cancer; 2019; 10(11):2457-2463. PubMed ID: 31258751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.